COMPARE · Reviewed July 29, 2026
ECG vs EXPO
Verdict: Side-by-side breakdown using the Bull Rankings model. ECG scored 72.0, EXPO scored 74.3 — EXPO leads.
Compare another set
ECG
Everus Construction Group, Inc.
72
$109.17 · $5.6B
fundamentals as of
Score gap
2.3
EXPO leads
EXPO
Exponent, Inc.
74.3
$65.84 · $3.2B
fundamentals as of
The model, pillar by pillar (0–100 each)
ECG
stronger →← stronger
EXPO
76
Qualityreturns · margins · balance sheet
93
89
Growthrevenue & earnings expansion
76
76
Valuevaluation vs sector peers
58
ECG is stronger on 2 of 3 pillars.
Fundamentals, head-to-head
ECG
EXPO
$230mC
FCF
$113mC
+29.7%A-
Rev
+7.8%B
0.53B+
D/E
0.24A-
25.0xB+
P/E
30.8xB
0.79A-
PEG
2.03C
Winner per row is the stronger grade in our model; a tie or a missing value shows no highlight.
Valuation · DCF cross-check
ECG
EXPO
39% above
Price vs fair valuelower is cheaper
23% above
~15%/yr
Growth the price implies10-yr FCF · lower = less priced in
~13%/yr
-35%
1-yr DCF upside
-28%
-28%
5-yr DCF upside
-19%
-17%
10-yr DCF upside
-4%
The DCF is a cross-check on intrinsic value, separate from the quality-growth score above.
Model signals
ECG
Why this score
- Durable high returns
- Short track record
EXPO
Why this score
- Buying back stock
- Raising its dividend
- Durable high returns
The companies
ECGEverus Construction Group, Inc.
Why now
Engineering & Construction · market cap $5.6b. Down 36% from 52-week high of $171.58 — deep drawdown territory. Revenue growing +30% — in hypergrowth territory. PEG 0.79 — paying under fair value for the growth rate. 5 sell-side analysts publish a mean 1-yr target of $169.60 (implying +55% upside).
Moat
ROE 33% — top-decile capital efficiency. Either pricing leverage, low capital intensity, or aggressive buybacks; the durability story depends on which. FCF converts 103% of net income — earnings translate cleanly into cash, a sign that working capital and capex are well-disciplined.
Risk
Down 36% from the 52-week high — the market is pricing in something the screen can't see; verify the bear case before sizing up.
EXPOExponent, Inc.
Why now
Engineering & Construction · market cap $3.2b. 20% off the 52-week high of $81.95. 3 sell-side analysts publish a mean 1-yr target of $81.67 (implying +24% upside).
Moat
Net margin 18% beats the market median by a meaningful margin — the company is keeping more of every revenue dollar than the average S&P constituent. ROE 32% — top-decile capital efficiency. Either pricing leverage, low capital intensity, or aggressive buybacks; the durability story depends on which. FCF converts 104% of net income — earnings translate cleanly into cash, a sign that working capital and capex are well-disciplined.
Risk
Trailing P/E 31x sits well above the S&P median (~20x) — multiple compression is a real risk if revenue growth decelerates.
Verdict — model-derived comparison
Generating verdict… typically 5–10 seconds
Not investment advice. The Bull Rankings publishes a quantitative ranking model and accompanying analysis for general informational purposes only. Nothing on this page is a recommendation to buy, sell, or hold any security; nothing is personalized to your circumstances, risk tolerance, or tax situation. Investing carries the risk of loss — invest at your own risk and consider consulting a licensed financial professional before acting on anything you read here. See terms and methodology for full disclosures.